NS 2028
Tocris Bioscience, part of Bio-Techne | Catalog # 4517
Potent soluble guanylyl cyclase (sGC) inhibitor
Key Product Details
Description
Potent soluble guanylyl cyclase (sGC) inhibitor
Product Description
NS 2028 is a potent soluble guanylyl cyclase (sGC) inhibitor (Ki = 8 nM). Blocks sGC activity in murine cerebellum induced by S-nitroso-glutathione and NMDA (IC50 values are 17 and 20 nM respectively). Inhibits VEGF-induced cGMP accumulation; abolishes VEGF-induced migration in postcapillary venular endothelial cells (CVEC).Product Specifications
Molecular Weight
269.05
Formula
C9H5BrN2O3
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one
CAS Number
204326-43-2
PubChem ID
4551
InChI Key
MUDRLQRJCGJJTB-UHFFFAOYSA-N
SMILES
BrC1=CC=C(OCC(N23)=NOC3=O)C2=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 26.91 | 100 | |
| Ethanol | 5.38 | 20 |
Preparing Stock Solutions
for NS 2028
The following data is based on the product molecular weight 269.05
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 3.72 mL | 18.58 mL | 37.17 mL |
| 5 mM | 0.74 mL | 3.72 mL | 7.43 mL |
| 10 mM | 0.37 mL | 1.86 mL | 3.72 mL |
| 50 mM | 0.07 mL | 0.37 mL | 0.74 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Morbidelli The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability. Am.J.Physiol.Regul.Integr.Comp.Physiol. 2010 PMID: 20032260
- Olesen Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br.J.Pharmacol. 1998 PMID: 9489619
- von Wantoch Rekowski Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase. Bioorg.Med.Chem. 2010 PMID: 20036129
Product Specific Notices for NS 2028
For research use only
Loading...
Loading...